Postoperative use of oral sildenafil in pediatric patients with congenital heart disease

Pediatric Cardiology

Volumn 31, Issue 4, 2010, Pages 515-520

  Uhm, Ju Yeon ^a   Jhang, Won Kyoung ^a   Park, Jeong Jun ^a   Seo, Dong Man ^a   Yun, Sung Cheol ^a   Yun, Tae Jin ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Congenital heart disease; Nitric oxide; Sildenafil

Indexed keywords

NITRIC OXIDE; SILDENAFIL;

ARTICLE; BLOOD PRESSURE MONITORING; BLOOD VESSEL REACTIVITY; CAVOPULMONARY CONNECTION; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DRUG EFFICACY; DRUG USE; FEMALE; FONTAN PROCEDURE; HEMODYNAMICS; HUMAN; INFANT; LUNG VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; OXYGEN SATURATION; POSTOPERATIVE PERIOD;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADOLESCENT; BLOOD PRESSURE; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HEART DEFECTS, CONGENITAL; HEMODYNAMICS; HUMANS; INFANT; INFANT, NEWBORN; MALE; NITRIC OXIDE; OXYGEN; PIPERAZINES; POSTOPERATIVE COMPLICATIONS; PULMONARY ARTERY; PULMONARY WEDGE PRESSURE; PURINES; RETROSPECTIVE STUDIES; SULFONES; TREATMENT OUTCOME; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 77954760631     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-009-9632-x     Document Type: Article

References (25)

1. Atz AM, Adatia I, Wessel DL (1996) Rebound pulmonary hypertension after inhalation of nitric oxide. Ann Thorac Surg 62:1759-1764.
2. Atz AM, Wessel DL (1999) Sildenafil ameliorates effects of inhaled nitric oxide withdrawal. Anesthesiology 91:307-310.
3. Bando K, Turrentine MW, Sharp TG, Sekine Y, Aufiero TX, Sun K et al (1996) Pulmonary hypertension after operations for congenital heart disease: Analysis of risk factors and management. J Thorac Cardiovasc Surg 112:1600-1609.
4. Cai J, Su Z, Shi Z, Zhou Y, Xu Z, Xu Z et al (2008) Nitric oxide and milrinone: combined effect on pulmonary circulation after Fontan type procedure: a prospective, randomized study. Ann Thorac Surg 86:882-888.
5. Celermajer DS, Cullen S, Deanfield JE (1993) Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics. Circulation 87:440-446.
6. Giardini A, Balducci A, Specchia S, Gargiulo G, Bonvicini M, Picchio FM (2008) Effects of silenafil on haemodynamic response to exercise and exercise capacity in Fontan patients. Eur Heart J 29:1681-1687.
7. Glavind-Kristensen M, Brix-Christensen V, Toennesen E, Ravn HB, Forman A, Sorensen K et al (2002) Pulmonary endothelial dysfunction after cardiopulmonary bypass in neonatal pigs. Acta Anaesthesiol Scand 46:853-859.
8. Hakim TS (1994) Flow-induced release of EDRF in the pulmonary vasculature: site of release and action. Am J Physiol 267(1 Pt 2):H363-H369.
9. Haseyama K, Satomi G, Yasukochi S, Matsui H, Harada Y, Uchita S (2006) Pulmonary vasodilation therapy with sildenafil citrate in a patient with plastic bronchitis after the Fontan procedure for hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 132:1232-1233.
10. Hopkins RA, Bull C, Haworth SG, de Leval MR, Stark J (1991) Pulmonary hypertensive crises following surgery for congenital heart defects in young children. Eur J Cardiothorac Surg 5:628-634.
11. Jackson G, Benjamin N, Jackson N, Allen MJ (1999) Effects of sildenafil citrate on human hemodynamics. Am J Cardiol 83:13C-20C.
12. Karatza AA, Bush A, Magee AG (2005) Safety and efficacy of sildenafil therapy in children with pulmonary hypertension. Int J Cardiol 100:267-273.
13. Khambadkone S, Li J, de Leval MR, Cullen S, Deanfield JE, Redington AN (2003) Basal pulmonary vascular resistance and nitric oxide responsiveness late after Fontan-type operation. Circulation 107:3204-3208.
14. Klodell CT Jr, Morey TE, Lobato EB, Aranda JM Jr, Staples ED, Schofield RS et al (2007) Effect of sildenafil on pulmonary artery pressure, systemic pressure, and nitric oxide utilization in patients with left ventricular assist devices. Ann Thorac Surg 83:68-71.
15. Lindberg L, Olsson AK, Jögi P, Jonmarker C (2002) How common is severe pulmonary hypertension after pediatric cardiac surgery? J Thorac Cardiovasc Surg 123:1155-1163.
16. Nemoto S, Umehara E, Ikeda T, Itonaga T, Komeda M (2007) Oral sildenafil ameliorates impaired pulmonary circulation early after bidirectional cavopulmonary shunt. Ann Thorac Surg 83:e11-e13.
17. Peiravian F, Amirghofran AA, Borzouee M, Ajami GH, Sabri M, Kolaee S (2007) Oral sildenafil to control pulmonary hypertension after congenital heart surgery. Asian Cardiovasc Thorac Ann 15:113-117.
18. Raja SG (2005) Milrinone for pulmonary hypertension: additional benefits, concerns, and caution. J Cardiothorac Vasc Anesth 19:134-135.
19. Raja SG, Danton MD, MacArthur KJ, Pollock JC (2007) Effects of escalating doses of sildenafil on hemodynamics and gas exchange in children with pulmonary hypertension and congenital cardiac defects. J Cardiothorac Vasc Anesth 21:203-207.
20. Rossi R, Nuzzo A, Lattanzi A, Coppi F, Modena MG (2008) Sildenafil improves endothelial function in patients with pulmonary hypertension. Pulm Pharmacol Ther 21:172-177.
21. Schulze-Neick I, Hartenstein P, Li J, Stiller B, Nagdyman N, Hübler M et al (2003) Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease. Circulation 108(Suppl 1):167-173.
22. Shim JK, Choi YS, Oh YJ, Kim DH, Hong YW, Kwak YL (2006) Effect of oral sildenafil citrate on intraoperative hemodyanmics in patients with pulmonary hypertension undergoing valvular heart surgery. J Thorac Cardiovasc Surg 132:1420-1425.
23. Stocker C, Penny DJ, Brizard CP, Cochrane AD, Soto R, Shekerdemian LS (2003) Intravenous sildenafil and inhaled nitric oxide: a randomized trial in infants after cardiac surgery. Intensive Care Med 29:1996-2003.
24. Uzun O, Wong JK, Bhole V, Stumper O (2006) Resolution of protein-losing enteropathy and normalization of mesenteric Doppler flow with sildenafil after Fontan. Ann Thorac Surg 82:e39-e40.
25. Wessel DL, Adatia I, Giglia TM, Thompson JE, Kulik TJ (1993) Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 88:2128-2138.